Please assess the completion status of the following clinical trial:

Trial Title: Quality of Life (QOL) in Female Patient With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis: Schizophrenia (DSM-IV)~2. Female, Age: between 18-60 years~3. Who either need first time treatment with antipsychotic drug or recently~4. Sign written informed consent~Exclusion Criteria:~1. Taking other psychiatric medications during last 30 days~2. Refractory schizophrenia~3. A current medical illness associated with sexual dysfunction~4. Previous history of no response to quetiapine or risperidone treatment~5. Previous enrolment or randomisation of treatment in the present study.~6. Participation in a clinical study during the last 90 days.~7. Pregnancy~8. Alcohol or substance abuser

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).